NCT00847405View on ClinicalTrials.gov

Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Healthy
Interventions
DRUG

Sumatriptan Succinate

100 mg Tablets

DRUG

Imitrex®

100 mg Tablet

Trial Locations (1)

M1L 4S4

Biovail Contract Research, Toronto

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00847405 - Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter